Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Moline › NPI 1164643623
Physician

Nwumeh, Emmanuel

Nwumeh, Emmanuel was paid $171K by Medicaid between Jan 2018 and Oct 2024, across 3 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 96% of everything it billed.

33Billing provider infoNWUMEH, EMMANUEL
MOLINE, IL 61265
33aNPI1164643623assigned 05/01/2007
28Total paid$171K
24GClaims2,735
24DCodes billed3
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers

Next to other Family Medicine Physician providers in Illinois

Rank by total paid#656 of 2,947
Median peer was paid$43K
This provider vs. median4.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0K$4.0K$6.0K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018366$23K
2019472$29K
2020434$27K
2021600$36K
2022371$28K
2023296$15K
2024incomplete196$13K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 96% 2,365 2,097 $164K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 3.5% 224 180 $6K
80305 <1% 146 138 $1K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.